Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 51 citing Quddusi: Differential effects of acute and extended infusions of glucagon-like peptide-1.... (0.11 sec) 

The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 …


DJ Drucker, MA Nauck - The Lancet, 2006 - Elsevier
Glucagon-like peptide 1 (GLP-1) is a gut-derived incretin hormone that
stimulates insulin and suppresses glucagon secretion, inhibits gastric emptying,
and reduces appetite and food intake. Therapeutic approaches for enhancing ...
Cited by 416 - Related articles - All 10 versions

Twelve-and 52-week efficacy of the dipeptidyl peptidase IV inhibitor LAF237 in metformin- …


B Ahrén, R Gomis, E Standl, D Mills, A … - Diabetes Care, 2004 - Am Diabetes Assoc
RESULTS—In patients randomized to LAF237, baseline HbA 1c averaged 7.7 ± 0.1%
and decreased at week 12 (Δ = −0.6 ± 0.1%), whereas HbA 1c did not change
from a baseline of 7.9 ± 0.1% in patients given placebo (between-group ...
Cited by 313 - Related articles - BL Direct - All 8 versions

Exenatide augments first-and second-phase insulin secretion in response to intravenous …

- endojournals.org
F Fehse, M Trautmann, JJ Holst, AE Halseth … - Journal of Clinical Endocrinology & Metabolism, 2005 - Endocrine Soc
Context: First-phase insulin secretion (within 10 min after a sudden rise in
plasma glucose) is reduced in type 2 diabetes mellitus (DM2). The incretin
mimetic exenatide has glucoregulatory activities in DM2, including glucose- ...
Cited by 123 - Related articles - BL Direct - All 4 versions

{beta}-Cell Failure in Diabetes and Preservation by Clinical Treatment

- endojournals.org
BL Wajchenberg - Endocrine reviews, 2007 - Endocrine Soc
There is a progressive deterioration in ß-cell function and mass in type 2
diabetics. It was found that islet function was about 50% of normal at the time
of diagnosis, and a reduction in ß-cell mass of about 60% was shown at ...
Cited by 105 - Related articles - BL Direct - All 7 versions

Glucagon-like peptide 1 (GLP-1) in biology and pathology


JJ Meier, MA Nauck - Diabetes/Metabolism Reviews - interscience.wiley.com
Post-translational proteolytic processing of the preproglucagon gene in the gut
results in the formation of glucagon-like peptide 1 (GLP-1). Owing to its
glucose-dependent insulinotropic effect, this hormone was postulated to ...
Cited by 73 - Related articles - All 3 versions

Incretin mimetics as emerging treatments for type 2 diabetes


SV Joy, PT Rodgers, AC Scates - The Annals of pharmacotherapy, 2005 - Harvey Whitney Books
Published Online, 23 November 2004, www.theannals.com, DOI 10.1345/aph.1E245.
The Annals of Pharmacotherapy: Vol. 39, No. 1, pp. 110-118. DOI
10.1345/aph.1E245 © 2005 Harvey Whitney Books Company.
Cited by 38 - Related articles - All 5 versions

Glucagon-like peptide 1: evolution of an incretin into a treatment for diabetes

- physiology.org
DA D'Alessio, TP Vahl - American Journal of Physiology- Endocrinology And …, 2004 - Am Physiological Soc
Glucagon-like peptide 1 (GLP-1) is a product of proglucagon that is secreted by
specialized intestinal endocrine cells after meals. GLP-1 is insulinotropic and
plays a role in the incretin effect, the augmented insulin response ...
Cited by 37 - Related articles - BL Direct - All 4 versions

Inhibition of DPP-4: a new therapeutic approach for the treatment of type 2 diabetes


RE Pratley, A Salsali - Current Medical Research and Opinion®, 2007 - informahealthcare.com
University of Vermont College of Medicine, Burlington, VT, USA ... Address for
correspondence: Richard E. Pratley, MD, Professor of Medicine, Director –
Diabetes & Metabolism Translational Medicine Unit, Department of Medicine, ...
Cited by 29 - Related articles - BL Direct - All 4 versions

Glucagon-like peptide-1 (GLP-1) receptors expressed on nerve terminals in the portal vein …

- endojournals.org
TP Vahl, M Tauchi, TS Durler, EE Elfers, TM … - Endocrinology, 2007 - Endocrine Soc
Glucagon-like peptide-1 (GLP-1) is an intestinal hormone that is secreted during
meal absorption and is essential for normal glucose homeostasis. However, the
relatively low plasma levels and rapid metabolism of GLP-1 raise questions ...
Cited by 28 - Related articles - BL Direct - All 2 versions

Gut peptides in the treatment of diabetes mellitus


TP Vahl, DA D'Alessio - eid, 2004 - Informa Pharma Science
It has been known for at least one century that agents secreted from the
intestine during meal absorption regulates glucose assimilation. Extensive
research during the past three decades has identified two gut hormones, ...
Cited by 24 - Related articles - All 4 versions


Result Page: 

1

2

3

4

5

6

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google